The board of directors of GlaxoSmithKline Pharmaceuticals Limited meeting held on May 17, 2023, recommended payment of final dividend INR 32.00 per equity share on face value of INR 10.00 each for the year ended 31st March 2023. Subject to the approval of members at 98th annual general meeting.